Imagion Biosystems Limited IBXXF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -32.15% | -31.95% | -393.75% | -378.56% | -5.78% |
| Total Depreciation and Amortization | -50.00% | -50.00% | -44.00% | -46.15% | -98.89% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 277.92% | 277.72% | 264.46% | 259.42% | -111.86% |
| Change in Net Operating Assets | -- | -- | -821.36% | -800.29% | -- |
| Cash from Operations | -11.36% | -11.19% | -104.96% | -98.71% | -1,001.16% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 12.00% | 12.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -34.03% | -34.03% | -- |
| Cash from Financing | -- | -- | -3.65% | -6.60% | -- |
| Foreign Exchange rate Adjustments | -54.84% | -56.67% | -202.56% | -200.00% | -210.71% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -12.58% | -12.40% | -57.56% | -58.86% | -1,217.97% |